S
Sanjay R. Mohan
Researcher at Vanderbilt University
Publications - 59
Citations - 1576
Sanjay R. Mohan is an academic researcher from Vanderbilt University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 17, co-authored 44 publications receiving 1157 citations. Previous affiliations of Sanjay R. Mohan include Cleveland Clinic & Vanderbilt University Medical Center.
Papers
More filters
Journal ArticleDOI
Aberrant DNA methylation is a dominant mechanism in MDS progression to AML
Ying Jiang,Andrew Dunbar,Lukasz P. Gondek,Sanjay R. Mohan,Manjot Rataul,Christine L. O'Keefe,Mikkael A. Sekeres,Yogen Saunthararajah,Jaroslaw P. Maciejewski +8 more
TL;DR: Results indicate that aberrant methylation can cooperate with chromosome deletions to silence TSG, and analysis of the most frequently aberrantly methylated genes identified FZD9 as a candidate TSG on chromosome 7.
Journal ArticleDOI
Anatomical grades of nerve sparing: a risk-stratified approach to neural-hammock sparing during robot-assisted radical prostatectomy (RARP)
Ashutosh Tewari,Abhishek Kumar Srivastava,Michael W. Huang,Brian D. Robinson,Maria M. Shevchuk,Matthieu Durand,Prasanna Sooriakumaran,Sonal Grover,Rajiv Yadav,Nishant Mishra,Sanjay R. Mohan,Danielle Brooks,Nusrat Shaikh,Abhinav Khanna,Robert Leung +14 more
TL;DR: In this article, a novel nerve-sparing approach to complete hammock preservation was presented, based on a periprostatic fascial dissection, which is more a network of multiple fine dispersed nerves than a distinct structure.
Journal ArticleDOI
Chronic myeloid leukemia, version 2.2021
Michael W. Deininger,Neil P. Shah,Jessica K. Altman,Ellin Berman,Ravi Bhatia,Bhavana Bhatnagar,Daniel J. DeAngelo,Jason Gotlib,Gabriela S. Hobbs,Lori J. Maness,Monica Mead,Leland Metheny,Sanjay R. Mohan,Joseph O. Moore,Kiran Naqvi,Vivian G. Oehler,Arnel Pallera,Mrinal M. Patnaik,Keith W. Pratz,Iskra Pusic,Michal G. Rose,B. Douglas Smith,David S. Snyder,Kendra Sweet,Moshe Talpaz,James E. Thompson,David T. Yang,Kristina M. Gregory,Hema Sundar +28 more
TL;DR: Tyrosine kinase inhibitor therapy is a highly effective first-line treatment option for all patients with newly diagnosed chronic phase CML.
Journal ArticleDOI
Myeloproliferative neoplasms, version 2.2018 featured Updates to the NCCN guidelines
Ruben A. Mesa,Catriona Jamieson,Ravi Bhatia,Michael W. Deininger,Christopher D.M. Fletcher,Aaron T. Gerds,Ivana Gojo,Jason Gotlib,Krishna Gundabolu,Gabriela S. Hobbs,Brandon McMahon,Sanjay R. Mohan,Stephen T. Oh,Eric Padron,Nikolaos Papadantonakis,Philip A. Pancari,Nikolai A. Podoltsev,Raajit K. Rampal,Erik A. Ranheim,Vishnu Reddy,Lindsay A.M. Rein,Bart L. Scott,David S. Snyder,Brady L. Stein,Moshe Talpaz,Srdan Verstovsek,Martha Wadleigh,Eunice S. Wang,Mary Anne Bergman,Kristina M. Gregory,Hema Sundar +30 more
TL;DR: The recommendations outlined in the NCCN Guidelines for the risk stratification, treatment, and special considerations for the management of PV and ET are discussed.
Journal ArticleDOI
Systemic Mastocytosis, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.
Jason Gotlib,Aaron T. Gerds,Prithviraj Bose,Mariana Castells,Michael W. Deininger,Ivana Gojo,Krishna Gundabolu,Gabriela S. Hobbs,Catriona Jamieson,Brandon McMahon,Sanjay R. Mohan,Vivian Oehler,Stephen T. Oh,Eric Padron,Philip A. Pancari,Nikolaos Papadantonakis,Animesh Pardanani,Nikolai A. Podoltsev,Raajit K. Rampal,Erik A. Ranheim,Lindsay A.M. Rein,David S. Snyder,Brady L. Stein,Moshe Talpaz,Swapna Thota,Martha Wadleigh,Katherine Walsh,Mary Anne Bergman,Hema Sundar +28 more
TL;DR: The recommendations outlined in the NCCN Guidelines for the diagnosis and management of patients with systemic mastocytosis are discussed.